Innovation Showcase
BioLamina can support scientists throughout their cell therapy development process– from concept to commercialized therapy. Our invited speakers will share their stories of translation success. It will be introduced and moderated by Dr. Graham, from BioLamina.
Dr. Hawkins will will focus on the development and manufacture of genetically stable, clinical-grade iPSC lines from regulatory-appropriate donor starting material.
Dr. Gaskell will share how Rinri Therapeutics has undertaken the journey from academic process to GMP translation. She will outline the fundamentals to building a control strategy to underpin translational success.
Finally, Dr. Eidhof will talk about how Defined culture conditions robustly maintain human stem cell pluripotency via tightly controlled Ca2+ signaling.